Researchmoz added Most up-to-date research on "Key Manufacturers Analysis Of Global Vaccine Technologies Market - Abbott Laboratories, Astellas Pharma Inc., Astrazeneca Plc and Bayer Animal Health" to its huge collection of research reports.
The global market for vaccine technologies reached $33.3 billion in 2016 and should reach $45.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2021.
Human vaccines as a segment of this market reached $27.2 billion in 2016 and should reach nearly $37.5 billion by 2021, growing at a CAGR of 6.6% from 2016 to 2021.
Animal vaccines as a segment of this market reached nearly $6.1 billion in 2016 and should reach $7.7 billion by 2021, growing at a CAGR of 4.9% from 2016 to 2021.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377101
Table Of Content
Chapter 1 INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
Chapter 2 EXECUTIVE SUMMARY
Chapter 3 OVERVIEW
Chapter 4 REGULATORY ASPECTS
Chapter 5 NEW DEVELOPMENTS
Chapter 6 MARKET ANALYSIS OF HUMAN VACCINES
Chapter 7 MARKET ANALYSIS OF ANIMAL VACCINES
Chapter 8 INDUSTRY STRUCTURE
Chapter 9 MARKET BY APPLICATION FOR HUMAN VACCINES
Chapter 10 PATENT ANALYSIS
Chapter 11 CURRENT SITUATION
Chapter 12 COMPANY PROFILES
Browse TOC @ https://www.researchmoz.us/global-markets-for-vaccine-technologies-report.html/toc
DEFINITIONS
THE IMMUNE SYSTEM
HOW VACCINES WORK
TYPES OF IMMUNITY
ADVANTAGES OF VACCINATION
HISTORY OF VACCINES
TYPES OF VACCINES
INFECTIOUS DISEASES PREVENTABLE BY VACCINES
ACTIVE
PASSIVE
ATTENUATED (LIVE) VACCINES
INACTIVATED (KILLED) VACCINES
TOXOID VACCINES
SUBUNIT VACCINES
CONJUGATE VACCINES
RECOMBINANT VECTOR VACCINES
DNA VACCINES
HUMAN DISEASES
ANIMAL DISEASES
Types of Attenuated (Live) Vaccines
Advantages and Disadvantages of Attenuated (Live) Vaccines
Types of Inactivated (Killed) Vaccines
Advantages and Disadvantages of Inactivated (Killed) Vaccines
Types of Toxoid Vaccines
Advantages and Disadvantages of Toxoid Vaccines
Types of Subunit Vaccines
Advantages and Disadvantages of Subunit Vaccines
Types of Conjugate Vaccines
Advantages and Disadvantages of Conjugate Vaccines
Types of Recombinant Vector Vaccines
Advantages and Disadvantages of Recombinant Vector Vaccines
Types of DNA Vaccines
Advantages and Disadvantages of DNA vaccines
Viral Diseases
Bacterial Diseases
Food-Producing Animals
The global market for vaccine technologies reached $33.3 billion in 2016 and should reach $45.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.3% from 2016 to 2021.
Human vaccines as a segment of this market reached $27.2 billion in 2016 and should reach nearly $37.5 billion by 2021, growing at a CAGR of 6.6% from 2016 to 2021.
Animal vaccines as a segment of this market reached nearly $6.1 billion in 2016 and should reach $7.7 billion by 2021, growing at a CAGR of 4.9% from 2016 to 2021.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377101
Table Of Content
Chapter 1 INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
Chapter 2 EXECUTIVE SUMMARY
Chapter 3 OVERVIEW
Chapter 4 REGULATORY ASPECTS
Chapter 5 NEW DEVELOPMENTS
Chapter 6 MARKET ANALYSIS OF HUMAN VACCINES
Chapter 7 MARKET ANALYSIS OF ANIMAL VACCINES
Chapter 8 INDUSTRY STRUCTURE
Chapter 9 MARKET BY APPLICATION FOR HUMAN VACCINES
Chapter 10 PATENT ANALYSIS
Chapter 11 CURRENT SITUATION
Chapter 12 COMPANY PROFILES
Browse TOC @ https://www.researchmoz.us/global-markets-for-vaccine-technologies-report.html/toc
DEFINITIONS
THE IMMUNE SYSTEM
HOW VACCINES WORK
TYPES OF IMMUNITY
ADVANTAGES OF VACCINATION
HISTORY OF VACCINES
TYPES OF VACCINES
INFECTIOUS DISEASES PREVENTABLE BY VACCINES
ACTIVE
PASSIVE
ATTENUATED (LIVE) VACCINES
INACTIVATED (KILLED) VACCINES
TOXOID VACCINES
SUBUNIT VACCINES
CONJUGATE VACCINES
RECOMBINANT VECTOR VACCINES
DNA VACCINES
HUMAN DISEASES
ANIMAL DISEASES
Types of Attenuated (Live) Vaccines
Advantages and Disadvantages of Attenuated (Live) Vaccines
Types of Inactivated (Killed) Vaccines
Advantages and Disadvantages of Inactivated (Killed) Vaccines
Types of Toxoid Vaccines
Advantages and Disadvantages of Toxoid Vaccines
Types of Subunit Vaccines
Advantages and Disadvantages of Subunit Vaccines
Types of Conjugate Vaccines
Advantages and Disadvantages of Conjugate Vaccines
Types of Recombinant Vector Vaccines
Advantages and Disadvantages of Recombinant Vector Vaccines
Types of DNA Vaccines
Advantages and Disadvantages of DNA vaccines
Viral Diseases
Bacterial Diseases
Food-Producing Animals
